Drug Trial Radar · NCT00000419
Safety of Estrogens in Lupus: Hormone Replacement Therapy
Last checked: Nov 20, 2026Latest source record: May 3, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
350
Actual
Start
Apr 1996
Primary completion
Not stated
Study completion Aug 2002
Sponsor
- Lead sponsor
- NYU Langone HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Research on Women's Health (ORWH)
- First posted
- Nov 4, 1999
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can safely use the hormone estrogen. In this part of the study, we will look at the effects of estrogen replacement therapy on the activity and severity of disease in women with SLE.
Conditions
- Systemic Lupus Erythematosus
Interventions
Premarin and ProveraDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
UAB Medical Center
Birmingham, Alabama
UCLA Medical Center, Dept. of Rheumatology
Los Angeles, California
University of Chicago Pritzker School of Medicine
Chicago, Illinois
Louisiana School of Medicine
Shreveport, Louisiana
Johns Hopkins Hospital
Baltimore, Maryland
Univ. of Michigan Med. Ctr., Rheumatology Div.
Ann Arbor, Michigan
Hospital for Joint Diseases
New York, New York
Hospital for Special Surgery
New York, New York
Albert Einstein College of Medicine, Jacoby Hospital, Dept. of Rheumatology
The Bronx, New York
UNC Medical Center, Dept. of Rheumatology
Chapel Hill, North Carolina
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma
Univ. of Pennsylvania Medical Center
Philadelphia, Pennsylvania
Univ. of Pittsburgh, Dept. of Rheumatology
Pittsburgh, Pennsylvania
University of Texas Health Sciences Center
Houston, Texas
Medical College of Virginia, Ambulatory Care Center
Richmond, Virginia
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.